ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have developed an artificial intelligence tool that may help predict serious cardiovascular problems many years before symptoms appear.
The system, known as...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have developed an artificial intelligence tool that may help predict serious cardiovascular problems many years before symptoms appear.
The system, known as...
WASHINGTON —The American College of Cardiology (ACC) is introducing a new cardiogenic shock designation to improve outcomes for one of the most life-threatening complications of a heart attack. The new designation builds on the success of the...
WASHINGTON —The American College of Cardiology (ACC) is introducing a new cardiogenic shock designation to improve outcomes for one of the most life-threatening complications of a heart attack. The new designation builds on the success of the...
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
At week 24 in the CORALreef Lipids and CORALreef HeFH trials, Merck's LIPFENDRA significantly reduced LDL-C by a placebo-adjusted 56% and 59%, respectively.
At week 24 in the CORALreef Lipids and CORALreef HeFH trials, Merck's LIPFENDRA significantly reduced LDL-C by a placebo-adjusted 56% and 59%, respectively.
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve.
The...
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve.
The...
Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
CHULA VISTA, CA. — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award winners of the 21st Annual Scientific Meeting (SCCT2026) in San Diego, Calif.
The SCCT Best Abstract Award – supported by...
CHULA VISTA, CA. — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award winners of the 21st Annual Scientific Meeting (SCCT2026) in San Diego, Calif.
The SCCT Best Abstract Award – supported by...
